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013.01.0Abstract Introduction, aim: In general, failure to decrease the extracellular ﬂuid volume despite
liberal use of diuretics is often termed diuretic resistance.
We aimed to correlate between urinary fractional sodium excretion as a marker of diuretic resis-
tance in patients admitted with congestive heart failure and its impact on length of hospital stay
together with in-hospital morbidity and mortality.
Patients and methods: 46 decompensated heart failure patients were enrolled in this study. We
decided that the urine sample from which we can calculate the FENa level will be a 24-hour sample
in an attempt to decrease the variability of FENa levels. FENa ¼ 100Na ðurinaryÞ
creatinine ðplasmaÞ=Na ðplasmaÞ  creatinine ðurinaryÞ
Intravenous furosemide was started on admission either as a continuous infusion or shots. It was
followed-up during the hospital stay for inhospital mortality and morbidity.
Results: FENa results came out with a median value of 1.5% with minimum and maximum FENa
results equal to 0.05% and 5.2%, respectively. The only three variables that contributed signiﬁ-
cantly to the prediction of hospital stay were Hb, LVEF, and FENa; with the latter variable show-
ing the most signiﬁcant relation.
Conclusion, recommendation: FENa can be used upon patient’s admission to guide therapy of heart
failure in an attempt to reduce the hospital stay.
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011. Introduction
Heart failure is a clinical syndrome resulting from a structural
or functional cardiac disorder that impairs the ability of the
ventricle to ﬁll with or eject blood commensurate with the
needs of the body, or that precludes it from doing so in the ab-
sence of increased ﬁlling pressure. A cardinal manifestation of
CHF is ﬂuid retention and ﬂuid accumulation that cause
congestion of the lungs, liver, intestines, and peripheralg by Elsevier B.V. All rights reserved.
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relieving the congestive symptoms that occur due to excess
ﬂuid accumulation. A variety of factors can account for persis-
tent ﬂuid retention in heart failure patients, including inade-
quate diuretic dose, excess sodium intake, delayed intestinal
absorption of oral diuretics, decreased diuretic excretion into
the urine, and increased sodium reabsorption at sites in the
nephron other than those inhibited by the diuretic.1–3
Although difﬁcult to quantify, diuretic resistance is thought
to occur in one of three patients with CHF. In moderate and
severe CHF patients, diuretic resistance occurs more fre-
quently and often becomes a clinical problem.4
Despite its frequency, the term ‘‘diuretic resistance’’ remains
inadequately deﬁned. In general, failure to decrease the extracel-
lular ﬂuid volume despite liberal use of diuretics is often termed
diuretic resistance. In clinical settings, diuretic resistance in edem-
atous patients has been deﬁned as a clinical state in which sodium
intake and excretion are equalized before adequate elimination of
ﬂuid occurs.4 More technically, diuretic resistance has been ex-
pressed as a fractional sodium excretion (FENa+) of <0.2%.
(FENa+) represents the amount of sodium excreted (mmol/time)
as a percentage of ﬁltered load.5
2. Aim of work
The aim of this observational study is to correlate between uri-
nary fractional sodium excretion as a marker of diuretic resis-
tance in patients admitted with congestive heart failure and its
impact on length of hospital stay together with inhospital mor-
bidity and mortality.
3. Patients and methods
46 patients admitted with a primary diagnosis of decompen-
sated heart failure were enrolled in this study [stage C HF
according to the AHA/ACC classiﬁcation] of whatever cause.
Exclusion criteria involved the following:
- Patients with normal left ventricular ejection fraction.
- Mild symptoms not necessitating adding or increasing the
dose of diuretics.
- Patients with chronic kidney disease (i.e. GFR <60 ml./
min/1.73 m2).
1- Full history and clinical examination.
2- Twelve lead electrocardiogram.
3- Chest X-ray.
4- Echocardiography:
Left ventricular systolic functions were assessed by measur-
ing the left ventricle end systolic dimension (LVESD), left ven-
tricle end diastolic dimension (LVEDD) by M-mode at the
parasternal long axis then reassessed by parasternal short axis
view upon which ejection fraction was calculated. Ejection
fraction was assessed by Simpson’s method in patients with
segmental wall motion abnormalities.19
5- Laboratory investigation:
Complete blood count.
Full kidney function test (serum creatinine, potassium, urea
and sodium levels).Full liver function test.
Full lipid proﬁle.
Fasting and post-prandial blood sugar.
Fractional excretion of sodium (FENa):
Characteristically, loop diuretics produce marked water
diuresis and natriuresis in heart failure patients in the ﬁrst
6 h after the intravenous dose; during this period, FENa can
peak at approximately 20–25%.6
However in another study it was found that following a single
dose of furosemide (1 mg/kg), peak FENa was achieved 30 min
following injection in the younger patients (17–40 years old) and
120 min following injection in older patients (75–80 years old).
Thus, timing of urine sample may lead to variability in the mea-
surement of FENa.7 Thus, we decided that the urine sample
from which we can calculate the FENa level will be a 24-h sam-
ple in an attempt to decrease the variability of FENa levels be-
tween the different timings of the urine sample collection.
It was calculated from spot creatinine and sodium (Na) lev-
els from a 24-h urine sample along with serum levels of sodium
and creatinine in the same 24-h period; it is calculated as
follows8:
FENa ¼ 100Na ðurinaryÞ
 creatinine ðplasmaÞ=Na ðplasmaÞ
 creatinine ðurinaryÞ
The 24-h urine collection was carried out as follows where
the patient discards the 1st discharged urine in early morning
then started to collect urine in a specially designed metered
container for the next 24-h till the 1st urination of the next
day and with this the collection process was completed.
Glomerular ﬁltration rate was estimated by the Cockcroft-
Gault equation:
CCr ðmL=minÞ
¼ ð140AgeÞ  lean body weight ½kg  0:85 ðif femaleÞ
serum Creatinine ½mg=dL  72
6- In-hospital management:
The patients were given a standard diet, receiving a deﬁned
ﬂuid (1.5 L/day) and a low salt (no more than 2.5 gm/day)
intake.
The patients were started on anti-failure medications
including ACEI/ARBs, spironolactone, BB and positive ino-
tropic agents if low cardiac output signs and symptoms were
present.
Intravenous furosemide was started on admission either as
a continuous intravenous infusion or in the form of intrave-
nous shots.
The patients were followed-up during the hospital stay for
the following:
In-hospital mortality and occurrence of malignant arrhyth-
mias (recurrent sustained ventricular tachycardia and torsades
de pointes ventricular tachycardia in the long QT syndrome),
duration of hospital stay.
4. Results
Of the 46 patients enrolled in this study; the median age was
59 years (29–79); the majority were of male gender
Figure 1 Inhospital outcome.
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(65.2%)}, hypertension {n= 30(65.2%)}, dyslipidemia
{n= 28(60.9%)}, coronary artery disease {n= 34(73.9)} and
history of smoking was reported {n= 31(67.4%)}. NYHA
heart failure class on admission revealed that 8(17.4%)
patients had NYHA class III and 38(82.6%) patients had a
NYHA class IV classiﬁcation. Table 1.
The mean systolic blood pressure on admission was
98 ± 19.2 mmHg and the mean diastolic blood pressure was
64 ± 11.4 mmHg with a mean pulse rate of 103.4 ± 12.7 beats
per minute.
The electrocardiogram revealed that 36(71.3%) patients
were in sinus rhythm while 10(21.7%) had atrial ﬁbrillation.
Also 8(17.4%) patients had left bundle branch block.
Their echocardiography showed an ejection fraction (EF)
with a median of 28% (27–38%). The left ventricular end-dia-
stolic dimension (LVEDD) had a median of 68 mm (59–
76 mm), while the median of the end-systolic dimension
(LVESD) was 55 mm (47–66 mm) and ﬁnally the right ventric-
ular systolic pressure (RVSP) had a median of 50 mmHg (20–
60 mmHg).
Laboratory workup revealed a hemoglobin count (Hb) with
a median of 12.2 (10, 16.9) gm/dl and a median for serum
potassium level (K+) measuring 3.8 (3.5, 4.8) mg/dl. The med-
ian creatinine clearance was 106 (91,125) ml/min/1.73 m2 while
the median levels of creatinine (S.Cr) and sodium (S.Na) were
0.8 (0.8, 1.3) mg/dl and 138 (132,143) mmol/L, respectively.
Also the medians for urinary excretion of creatinine and so-
dium were 55 (17.3, 80.2) mg/dl and 83 (44, 112) mmol/L,
respectively. The daily urine volume had a median of 2100
(1400, 4700) ml/day.
FENa results came out with a median value of 1.5% with
minimum and maximum values equal to 0.05% and 5.2%,
respectively.
5. Follow-up characteristics
In-hospital follow-up for morbidity and mortality showed that
there were no mortalities and three patients had sustained ven-
tricular tachycardia that required DC shock. Only 2(4.3%) pa-
tients had symptoms and signs of low cardiac output state,
while the rest 41(89%) patients had an event-free hospital stay.
Fig. 1.
The mean hospital stay was 8 ± 4.2 days with a minimum
of 4 days and a maximum of 22 days.Table 1 Demographic and risk factors of the studied group.
Parameter
Age (years)
Range (min–max) 29–79
Gender
Male/female {n (%)} 41/5
(89.1%/10.9%)
DM 65.2%
HTN 55.2%
DYSLIP 60.9%
SMOKING 67.4%
Coronary artery disease 73.9%
*Data are expressed as number (%).6. Correlation between the fractional excretion of sodium
(FENa) and different clinical variables
The correlation between the hospital stay and the log of the
FENa percentage was r= 0.489 with p= 0.0006. This result
is with the outlier excluded, but when the outlier is included,
Pearson’s correlation drops to 0.33, but the p-value is still
signiﬁcant at p= 0.021. Therefore there is a signiﬁcant inverse
correlation between FENa and hospital stay. Fig. 2.
There was no correlation between FENa and NYHA class
on admission (r= 0.09, p= 0.51) or with the left ventricular
ejection fraction (LVEF) (r= 0.04, p= 0.77). Also no cor-
relation was found between FENa and the total furosemide
dose per day (r= 0.07, p= 0.64).
A multiple regression model was run with the dependent
variable log (FENa), predicted by the independent variables:
Diabetes Mellitus (DM), Hypertension (HTN), Dyslipidemia,
and Coronary Artery Disease (CAD). None of these variables
showed a signiﬁcant relation to FENa.
As a way to identify the independent predictor(s) of length
of hospital stay, a multiple linear regression analysis was done
putting in the model the different clinical variables such as
hemoglobin level (Hb), serum sodium level, Left ventricular
ejection fraction (LVEF), heart Failure classiﬁcation, and
FENa.
The only three variables that contributed signiﬁcantly to
the prediction of hospital stay were Hb, LVEF, and FENa;Figure 2 Correlation between FENa and length of hospital stay.
Table 2 Independent predictors of length of hospital stay.
Independent predictor of length of hospital stay p-Value
Hb 0.01Signif.
Serum Na+ 0.1NS
LVEF 0.003Signif.
Lasix dose/day 0.4NS
NYHA classif. 0.4NS
Log (FENa) 0.00005Signif.
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Table 2.
7. Discussion
Fractional excretion of sodium (FENa) was used in various
previous studies to assess the effectiveness of diuresis in heart
failure.
Data included in these studies showed that baseline FENa
in these patients is approximately less than 1% indicating
pre-renal azotemia due to renal hypoperfusion.9–11
In a subset group of these patients a baseline pre-treatment
FENa of less than 0.2% was considered to have diuretic
resistance.1
The aim of this study was to ﬁnd out if there was a corre-
lation between FENa and in-hospital morbidity and mortality.
As regards the in-hospital duration of stay there was a signif-
icant inverse correlation between both variables (p= 0.0006).
FENa reﬂects net sodium ﬁltration and reabsorption from
multiple nephron segments; loop diuretics block sodium reab-
sorption on the loop of Henle, while having no effect on the
proximal tubule. Decreased renal blood ﬂow in severe systolic
heart failure may promote sodium reabsorption from this seg-
ment, thus decreasing FENa. In our study, we did not ﬁnd a
signiﬁcant correlation between FENa (calculated from a 24-h
urine sample) and ejection fraction (r= 0.04; p= 0.7). This
was discordant with previous studies that have noticed a
strong correlation between the cardiac index of heart failure
patients measured by the thermo-dilution method, and their
FENa calculated before starting the loop diuretic piretanide
(r= 0.85; p< 0.01).12 While other studies correlated FENa
with the ejection fraction where FENa was calculated at least
6 h after the administration of intravenous loop diuretics and
again there was a signiﬁcant correlation between both vari-
ables (r= 0.48, p= 0.015).13
Also we could not ﬁnd a signiﬁcant correlation between the
total diuretic dose per day and FENa values.
The median length of hospital stay was 7 days in compari-
son with 5 days for patients in American hospitals in the past
few years.14
A multivariate regression model with other variables that
might have inﬂuence on hospital-stay (including low ejection
fraction, hemoglobin level, serum sodium level, HF classiﬁca-
tion on admission, furosemide dose per day and FENa) was
done. When the histogram of hospital stay was plotted, we no-
ticed that the highest probability of stay is the shortest possi-
ble, and that higher numbers of days were of gradually lower
probability. This is quite similar to a Poisson distribution;
therefore the model was ﬁt, assuming this distribution. The re-
sults revealed a signiﬁcant impact of Hb (p= 0.01), LVEF(p= 0.003) and FENa (p= 0.00005) on the length of hospital
stay with the latter variable having the strongest impact by an
increase in the length of stay.
Furthermore, Harjal et al. found a signiﬁcant inverse
correlation between FENa and LVEF.15 The same goes for
the decrease in hemoglobin count that is associated with an
increased stay.16
In our study we did not ﬁnd any association between
NYHA class and the length of stay which was consistent with
another trial that showed no association.17
May be the only contradicting result was that of the admis-
sion of serum sodium level that had no correlation with the
length of stay and this was against the data posted by Callahan
et al. that found that low sodium level was a signiﬁcant predic-
tor of increased hospital stay.18
The signiﬁcance of FENa level as a predictor of hospital
stay was quite remarkable although it was not the only predic-
tor of hospital stay but was certainly the most signiﬁcant.
8. Conclusion, recommendation
The fractional excretion of sodium test was proved to have the
strongest impact on hospital stay among other determinants
such as low hemoglobin level and low ejection fraction. It
can be used upon patient’s admission and after the initiation
of intravenous loop-diuretics to guide therapy with combina-
tion therapies with other classes of diuretics in an attempt to
reduce the hospital stay of heart failure patients. Larger num-
ber of patients is needed to detect cut-off values for FENA to
determine diuretic resistant patients.
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